The AACR Cancer Disparities Progress Report 2024 is now available online. The report provides a comprehensive overview of the latest research on cancer disparities and calls for policies to reduce disparities and achieve cancer health equity.
Read the Report
Thanks to spectacular research-driven advances, more than 18 million people in the United States and millions more worldwide are cancer survivors living with, through, and beyond their disease.
Learn MoreRead the stories of cancer survivors and patients featured in the new AACR Cancer Disparities Progress Report 2024.
Read the ReportMore than 106,000 people in the U.S. are expected to be diagnosed with melanoma this year. May is Melanoma and Skin Cancer Awareness Month. Learn more about the prevention, screening, and treatment options.
Learn MoreGet updates on research driven advances in cancer science and medicine including the recent AACR Annual Meeting 2024 in San Diego on the AACR Blog.
Read the AACR BlogRead about recent U.S. Food and Drug Administration approvals of products for cancer prevention, diagnosis, and treatment.
Learn MoreWhether honoring a special person or a special day, a donation to the American Association for Cancer Research has a lasting impact.
Donate NowThe official news website of the AACR Annual Meeting 2024. Stay up to date on the latest developments from the most important cancer meeting in the world.
The AACR Cancer Disparities Progress Report 2024 outlines the complex interplay of factors that drive and perpetuate cancer health disparities and calls for a collaborative approach to achieve health equity.
Learn MoreThe AACR and its more than 58,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreDr. Winn, chair of the AACR Cancer Disparities Progress Report 2024 steering committee, discusses the many factors that drive and perpetuate cancer health disparities.
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2020
Learn Moretherapeutics were approved for new or expanded uses by the FDA from Aug. 1, 2022, to July 31, 2023
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn MoreYour donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now
